Humana Inc(HUM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 5:34 PM ET (Korea 10/29 06:34)
Full metrics table
| Index | S&P 500 | P/E | 39.01 | EPS (ttm) | 10.56 | Insider Own | 0.27% | Shs Outstand | 120.1M | Perf Week | -3.19% |
| Market Cap | 49.46B | Forward P/E | 24.29 | EPS next Y | 85.16% | Insider Trans | - | Shs Float | 119.8M | Perf Month | 6.46% |
| Enterprise Value | - | PEG | 1.15 | EPS next Q | -1 | Inst Own | 101.91% | Short Float | 3.06% | Perf Quarter | 12.33% |
| Income | 1.28B | P/S | 0.34 | EPS this Y | -46.56% | Inst Trans | 1.81% | Short Ratio | 2.73 | Perf Half Y | 69.41% |
| Sales | 145.68B | P/B | 2.57 | EPS next 5Y | 21.2% | ROA | 2.38% | Short Interest | 3.67M | Perf YTD | 60.81% |
| Book/sh | 160 | P/C | - | EPS past 3/5Y | -23.63% -17.23% | ROE | 6.83% | 52W High | -9.78% ($456.50) | Perf Year | 39.71% |
| Cash/sh | - | P/FCF | 25.38 | Sales past 3/5Y | 11.76% 10.94% | ROIC | 4.1% | 52W Low | 152.51% ($163.11) | Perf 3Y | -19.27% |
| Dividend Est. | $3.69 (0.9%) | EV/EBITDA | - | EPS Y/Y TTM | -18.53% | Gross Margin | - | Volatility(W/M) | 2.56% 3.74% | Perf 5Y | -11.92% |
| Dividend TTM | 2.66 | EV/Sales | - | Sales Y/Y TTM | 18.33% | Oper. Margin | 1.86% | ATR (14) | 15.38 | Perf 10Y | 140.78% |
| Dividend Ex-Date | 2026/10/30 | Quick Ratio | - | EPS Q/Q | 26.93% | Profit Margin | 0.88% | RSI (14) | 51.06 | Recom | 2.13 |
| Dividend Gr. 3/5Y | 3.97% 7.2% | Current Ratio | 1.74 | Sales Q/Q | 26.18% | SMA20 | -0.43% ($413.65) | Beta | 0.67 | Target Price | $460.46 |
| Payout | 36% | Debt/Eq | 0.74 | Earnings | 2026/11/6 | SMA50 | 3.08% ($399.56) | Rel Volume | 0.72 | Prev Close | $414.85 |
| Employees | 67060 | LT Debt/Eq | 0.62 | EPS/Sales Surpr. | 4.7% 0.71% | SMA200 | 34.19% ($306.93) | Avg Volume(3M) | 1.34M | Price | $411.87 |
| IPO | 1969/7/2 | Option/Short | Yes/Yes | Trades | 12697 | Volume | 965,138 | Change | -0.72% |
A leading health insurer in the U.S. Medicare Advantage (MA) market. Founded in 1961 and headquartered in Louisville, Kentucky, the company serves as a key pillar of a major U.S. health insurance group, offering an integrated suite of services that includes Medicare Advantage plans for individuals aged 65 and over, Medicaid, prescription drug plans (PDP), group commercial insurance, and CenterWell's in-house primary care and pharmacy services.
Over the past 1 year, on the higher side
10% below its 1-year high.
Traded less than usual. That is 72% of its average volume.
Next earnings report: November 6
9 days to go. The ex-dividend date is October 30.
HUM has weak earning power
Of every $100 in sales, $1.86 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -46.6% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $3,901. Peers typically go for $2,966. Compared with its own 5-year average, it is 108% pricier now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -11.9%. The S&P 500 did +69% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.90% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 101.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #5 of 11 in the industry
Based on market cap of $49B.
FAQ
What kind of company is HUM?
HUM belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of HUM?
The market cap of HUM is approximately $49.5B, ranking 322 within its sector.
Does HUM pay dividends?
HUM has a dividend yield of approximately 0.90%, with an annual dividend of $3.69.
What is the P/E ratio of HUM?
HUM has a P/E ratio of approximately 39.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for HUM?
HUM has recorded a 52-week high of $456.50 and a low of $163.11.
